Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XCDENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.44.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
FL.37ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.45.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FP.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.102ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FK.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GN.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.31ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CE.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EA.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.22ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DH.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XGENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.3.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.70ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.63ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.4.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.8.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EC.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BM.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XLENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BD.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.87 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.23.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XNENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.111 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BM.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.31ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.30ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CG.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.20ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1.30ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.5.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.37ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.57ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CN.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.4.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.54ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.18ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.52ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BL.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used